## Core Concept
CD59, also known as protectin, is a surface protein that inhibits the formation of the complement membrane attack complex (MAC) by binding to complement components and preventing their assembly into the membrane. This protein plays a critical role in protecting cells from complement-mediated lysis.

## Why the Correct Answer is Right
CD59 deficiency leads to **Paroxysmal Nocturnal Hemoglobinuria (PNH)**. PNH is a rare, acquired, life-threatening disease of the blood characterized by the destruction of red blood cells (hemolysis), bone marrow failure, and the presence of blood clots. The deficiency of CD59, along with deficiencies of CD55, allows the complement system to lyse red blood cells uncontrollably, leading to the clinical manifestations of PNH.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because while CD55 deficiency is also associated with PNH, the question specifically asks about CD59 deficiency.
- **Option B:** This option is incorrect as there is no well-known condition directly linked to CD59 deficiency alone that is widely recognized by this name or description.
- **Option C:** This option might seem plausible because while issues with the complement system are involved, CD59's role is more specifically related to protection against MAC formation rather than broader immune complex deposition diseases.

## Clinical Pearl / High-Yield Fact
A key point to remember is that PNH is caused by mutations in the **PIGA gene**, which is necessary for the synthesis of GPI (glycosylphosphatidylinositol), the anchor that attaches both CD55 and CD59 to the cell surface. Without this anchor, cells lack these protective proteins, making them susceptible to complement-mediated destruction.

## Correct Answer: D. Paroxysmal Nocturnal Hemoglobinuria (PNH).